Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Seminars in Arthritis and Rheumatism
|
September 5, 2016
Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
Lisa Stamp, Nicola Dalbeth
Seminars in Dialysis
|
September 28, 2007
Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events
Nicola Dalbeth, Lisa Stamp
Annals of the Rheumatic Diseases
|
April 11, 2014
Hyperuricaemia and gout: time for a new staging system?
Nicola Dalbeth, Lisa Stamp
Nature Reviews. Rheumatology
|
August 20, 2014
Screening for hyperuricaemia and gout: a perspective and research agenda
Lisa Stamp, Nicola Dalbeth
Biochemical and Biophysical Research Communications
|
August 26, 2014
Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment
Claudia Knake, Lisa Stamp, Andrew Bahn
Drugs
|
January 6, 2006
Gout in solid organ transplantation: a challenging clinical problem
Lisa Stamp, Martin Searle, John O'Donnell, et al.
The Journal of Rheumatology
|
June 20, 2006
Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout
Nicola Dalbeth, Sunil Kumar, Lisa Stamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2019
Reply
Hyon Choi, Tuhina Neogi, Lisa Stamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 6, 2018
New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
Hyon Choi, Tuhina Neogi, Lisa Stamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 9, 2018
Reply
Hyon Choi, Tuhina Neogi, Lisa Stamp, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Seminars in Arthritis and Rheumatism
|
September 5, 2016
Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
Lisa Stamp, Nicola Dalbeth
Seminars in Dialysis
|
September 28, 2007
Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events
Nicola Dalbeth, Lisa Stamp
Annals of the Rheumatic Diseases
|
April 11, 2014
Hyperuricaemia and gout: time for a new staging system?
Nicola Dalbeth, Lisa Stamp
Nature Reviews. Rheumatology
|
August 20, 2014
Screening for hyperuricaemia and gout: a perspective and research agenda
Lisa Stamp, Nicola Dalbeth
Biochemical and Biophysical Research Communications
|
August 26, 2014
Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment
Claudia Knake, Lisa Stamp, Andrew Bahn
Drugs
|
January 6, 2006
Gout in solid organ transplantation: a challenging clinical problem
Lisa Stamp, Martin Searle, John O'Donnell, et al.
The Journal of Rheumatology
|
June 20, 2006
Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout
Nicola Dalbeth, Sunil Kumar, Lisa Stamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2019
Reply
Hyon Choi, Tuhina Neogi, Lisa Stamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 6, 2018
New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
Hyon Choi, Tuhina Neogi, Lisa Stamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 9, 2018
Reply
Hyon Choi, Tuhina Neogi, Lisa Stamp, et al.
Page
of 5